Infection syndrome | Description | Discriminating factors | Author |
Risk of CPE in CAP | 6 point score: score 2+ positive/negative predictive values 17.7%/98.5% | Albumin <30 g/l, CRP >100 mg/l, platelet count >400×109/l, Na+ <130 mmol/l, injecting drug use, alcohol overuse (all +1), COPD (protective, −1) | Chalmers43 |
CAP 90 day mortality | Weighted score: 0–2, 0.7%; 3–7, 3.5%; >7, 17.2% mortality | Baseline functional status (Katz index), co-morbidities (Charlson index), CURB score | Capelastegui47 |
PCP | 6 point score for mortality risk (score 0–1, 4%; 2–3, 12%; 4–5, 48%) | Age >40, albumin <30 g/l, bilirubin >6 mg/l, alveolar-arterial oxygen gradient >50 mm Hg, intravenous drug use (all +1) | Fei49 |
Pulmonary TB, sputum smear positive | Prediction of treatment response from radiology scoring: score >71, 80% sensitive/68% specific persistent smear-positive sputum after 2 months treatment | Score=proportion of lung affected (%) + 40 if cavitation present on baseline frontal chest radiograph | Ralph50 |
CAP, community acquired pneumonia; CPE, complex pleural effusions; CRP, C-reactive protein; PCP, Pneumocystis jirovecii pneumonia; TB, tuberculosis.